Dr. Nao Gamo, a highly regarded neuroscientist and entrepreneur, has recently assumed the role of Chief Operating Officer at the MDC-Verte Fund. This significant appointment adds to her already impressive track record, which includes her previous position as Vice President of Business Development at MDC Studio and her role as the Founder and CEO of a grant consulting firm. Dr. Gamo is also recognized for her involvement as the Chair of the Women in Bio – Capital Region Chapter.
The MDC-Verte Fund, located in Baltimore, is a joint effort between MDC Studio and the Verte Opportunity Zone Fund, Inc. The fund focuses on providing early-stage investment capital to drive innovation in emerging companies, particularly within the field of medtech startups where securing funding is often a limiting factor due to the resource-intensive nature of deep-tech innovation.
In her new role, Dr. Gamo will be tasked with identifying and evaluating early-stage medical technology companies in federally designated Opportunity Zones, as well as conducting due diligence and facilitating investments in these companies. She is enthusiastic about the opportunity to work with high-growth, socially impactful companies, and to be part of a team dedicated to making a positive economic impact in the community.
Dr. Gamo’s background includes 15 years of experience as an academic researcher in neuroscience, and she has seamlessly transitioned into the world of entrepreneurship. She holds a PhD in Neurobiology from Yale University and has completed a Postdoctoral Fellowship in the Molecular Psychiatry Program at the Johns Hopkins University. Additionally, her credentials include a double major in Brain and Cognitive Sciences and Music from the Massachusetts Institute of Technology.
Aside from her professional roles, Dr. Gamo is actively involved in the community and holds positions on various boards and committees. She is a Board member and volunteer for the Metro Baltimore chapter of NAMI and serves as the Chair of the Executive Women in Bio Committee for the Capital Region Chapter of Women in Bio. Dr. Gamo has received recognition for her contributions, including being named as a RealLIST Connector in 2021 and receiving the Women in Bio Capital Region Chapter’s 2021-2022 Rising Star award.
In conclusion, Dr. Nao Gamo’s appointment as the Chief Operating Officer of the MDC-Verte Fund is a testament to her expertise and dedication in the fields of neuroscience and entrepreneurship. Her diverse background and commitment to driving innovation make her a valuable asset to the fund’s mission of supporting early-stage companies in the medtech industry.
This information is sourced from BioBuzz, a leading media and events company focused on the biotech and life sciences sector, providing invaluable insights, industry updates, and resources for business and career growth in the BioHealth Capital Region and Greater Philadelphia.
+ There are no comments
Add yours